Clinical Trials for Breast Cancer Stage IV

Find clinical trials for breast cancer stage iv. Discover research opportunities and treatment options in your area.

17 Active Trials Found

Showing 17 trials on this page

Page 1 of 1

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

NCT ID: NCT07030569

This clinical trial, called RADIOSPHER2, is studying a new way to use medical images (like CT and PET scans) to better understand a protein called HER2 in patients with metastatic breast cancer—tha...

Recruiting

Type: observational Locations: Milan, , Italy

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT ID: NCT06678269

This clinical trial is investigating the use of a medication called abemaciclib in combination with radiation therapy for people with metastatic breast cancer, which is cancer that has spread beyon...

Recruiting

Phase: PHASE1 Type: interventional Locations: Harrison, New York, United States, Middletown, New Jersey, United States +5 more

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

NCT ID: NCT06680596

This clinical trial is investigating a new treatment for patients with advanced breast cancer that has spread to other parts of the body, specifically those whose tumors have low levels of a protei...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Villejuif, , France

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT ID: NCT06246968

This clinical trial is looking at the use of a medication called pembrolizumab, combined with a treatment called cryoablation, for people with advanced types of breast cancer, especially those with...

Recruiting

Phase: PHASE1 Type: interventional Locations: Middletown, New Jersey, United States, Montvale, New Jersey, United States +5 more

HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

NCT ID: NCT06830382

The HER2-PET trial is a research study aimed at improving treatment for women with advanced breast cancer that expresses a protein called HER2. This trial will use a special imaging technique calle...

Not yet recruiting

Phase: PHASE2 Type: interventional

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

NCT ID: NCT05625087

This clinical trial, called SAFIR 03, is researching a new way to help patients with advanced breast cancer choose the best treatment options. Specifically, it looks at the presence of mutated tumo...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nice, , France, Clermont Ferrand, , France +43 more

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT ID: NCT06805812

The PALMARES-2 study is looking at how well certain treatments work for patients with advanced hormone receptor-positive, HER2-negative breast cancer. Specifically, it focuses on patients who are r...

Recruiting

Type: observational Locations: Rozzano, , Italy, Genova, , Italy +22 more

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

NCT ID: NCT06075810

This clinical trial is studying a new oral medication called MBQ-167 for patients with advanced breast cancer. It is specifically designed for individuals whose previous treatments have not worked ...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Juan, , Puerto Rico, Nashville, Tennessee, United States +2 more

Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer

NCT ID: NCT06578299

This clinical trial is studying a new treatment approach for women with advanced breast cancer that tests positive for a protein called HER2. The researchers want to see how well the combination of...

Not yet recruiting

Phase: PHASE4 Type: interventional

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

NCT ID: NCT06268665

This clinical trial is studying whether tart cherry juice can help prevent nerve damage (neuropathy) caused by a chemotherapy drug called paclitaxel, which is commonly used to treat breast and ovar...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan

NCT ID: NCT06236269

This clinical trial is studying a treatment called sacituzumab govitecan for patients with advanced or metastatic breast cancer, specifically those whose cancer is hormone receptor-positive (HR+) a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain, Madrid, , Spain +8 more

SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells

NCT ID: NCT04150042

The SHARON clinical trial is studying a new treatment approach for patients with advanced (stage IV) cancer who have specific genetic mutations called BRCA1, BRCA2, or PALB2. This treatment combine...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States

A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.

NCT ID: NCT04469127

This clinical trial is testing a new treatment called Lutetium-177-DOTAGA-IAC (also known as HurlutinTM Lu-177) for patients with advanced breast cancer that is not surgically removable. Specifical...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, New Delhi, Dehli, India +2 more

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

NCT ID: NCT05033925

This clinical trial is looking at the safety and benefits of using a natural remedy called Awar-Awar leaf, which comes from the Ficus Septica plant, as an additional treatment for women with stage ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Semarang, Jawa Tengah, Indonesia

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

NCT ID: NCT05866432

This clinical trial is studying a new treatment called datopotamab-deruxtecan (Dato-DXd) for patients with stage IV triple-negative breast cancer who have brain metastases, meaning the cancer has s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Vienna, , Austria

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

NCT ID: NCT05860907

This clinical trial is studying a treatment called Huaier Granules for patients with advanced breast cancer that hasn't spread to vital organs. The goal is to see how effective and safe this treatm...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Zhengzhou, Henan, China, Shanghai, Shanghai, China +11 more

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

NCT ID: NCT05377047

The TAORMINA trial is a research study looking at a treatment for patients with a specific type of breast cancer called oligometastatic breast cancer (OMBC), which means the cancer has spread to 1 ...

Recruiting

Phase: NA Type: interventional Locations: Gothenburg, , Sweden, Gothenburg, Västra Götalandsregionen, Sweden

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions